Brief: Marinus Pharmaceuticals Says Co Will Defend Its Patents Amidst IPR Challenge From Ovid Therapeutics
27/03/2024 12:47
March 27 (Reuters) - Marinus Pharmaceuticals Inc
MRNS.O :
* MARINUS PHARMACEUTICALS COMMENTS ON PATENT CHALLENGE BY
OVID
THERAPEUTICS INC. AND PROVIDES UPDATE ON MARINUS’ POST GRANT
REVIEW
* MARINUS PHARMACEUTICALS INC - WILL DEFEND OUR PATENTS
* MARINUS PHARMACEUTICALS INC: IN RESPONSE TO MARINUS'
REQUEST FOR
POST-GRANT REVIEW, OVID THERAPEUTICS ABANDONED 23 OF 31 CLAIMS
IN ITS PATENT
Source text for Eikon: ID:nBw6tnM1Ya
Further company coverage: MRNS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marinus Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP- Axsome Therapeutics, Ducommun, Vacasa
Brief: Immedica To Acquire Biopharmaceutical Company Marinus Pharmaceuticals
Marinus Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Appfolio, S&P Global, Uber
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group